EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms

Fumihiko Yasuno, Kazuyuki Nakagome, Yoshie Omachi, Yasuyuki Kimura, Aya Ogata, Hiroshi Ikenuma, Junichiro Abe, Hiroyuki Minami, Takashi Nihashi, Kastunori Yokoi, Saori Hattori, Nobuyoshi Shimoda und 6 weitere

Brain, Behavior, & Immunity - Health · 2025-08 · 47 · 101018

DOI: 10.1016/j.bbih.2025.101018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2025-08. Verfasst von Fumihiko Yasuno und 17 weiteren Autor:innen. Beteiligte Einrichtung: National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, National Center for Geriatrics and Gerontology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chronic peripheral inflammation triggered by adipokine release may extend to the brain, potentially influencing the pathological progression of Alzheimer's disease (AD) and neuropsychiatric symptoms (NPS). However, it remains unclear whether and how leptin contributes to the link between adipose tissue dysfunction and dementia. This study aims to investigate the role of leptin in the connection between adipose-derived inflammatory signaling and cognitive impairment/NPS.

Methods

Path analysis was employed to explore how leptin relates to the association between adipose-related metabolic dysfunction and dementia through inflammatory pathways in patients with AD pathology (n = 15). Variables included plasma leptin concentration, body mass index (BMI) as a marker of adiposity, and in vivo assessments of regional neuroinflammation using translocator protein (TSPO)-PET imaging with the tracer 11C-DPA-713 (11C-DPA-713-binding potential [11C-DPA-713-BPND]). Cognitive function was measured using the Alzheimer's Disease Assessment Scale-Japanese Cognitive Subscale (ADAS-J cog), while NPS were assessed using the Neuropsychiatric Inventory Questionnaire (NPI-Q).

Results

Regression analysis demonstrated that higher plasma leptin concentrations positively correlated with BMI and significantly predicted 11C-DPA-713-BPND in the insula. Additionally, NPI-Q scores were associated with 11C-DPA-713-BPND in the insula. Path analysis supported leptin's role linking adiposity to NPS through insular inflammation. The hypothesized model fit the data well under the null hypothesis [χ2 (3) = 0.63, p = 0.89].

Discussion

These findings underscore the relevance of exploring how leptin and adipose tissue dysfunction interact with neuroinflammatory processes in contributing to NPS in the patients in the AD continuum. Interventions targeting these interactions could represent promising avenues for managing NPS.

Schlagwörter

Stichwörter der Autor:innen

AdiposityAlzheimer's diseaseInsulaLeptinNeuroinflammationNeuropsychiatric symptomsPositron emission tomography

Autor:innen und Institutionen

  • National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Department of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Department of Psychiatry, National Center of Neurology and Psychiatry, Kodaira, Japan.
  • Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science, Kani, Japan.
  • Functional Genomics Unit, Medical Genome Center, National Center for Geriatrics and Gerontology, Obu, Japan.
  • Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • National Center for Geriatrics and Gerontology
  • Japan Agency for Medical Research and Development
  • Japan Health Research Promotion Bureau

Zitieren

APA

Yasuno, F., Nakagome, K., Omachi, Y., Kimura, Y., Ogata, A., Ikenuma, H., Abe, J., Minami, H., Nihashi, T., Yokoi, K., Hattori, S., Shimoda, N., Kasuga, K., Ikeuchi, T., Takeda, A., Sakurai, T., Ito, K., & Kato, T. (2025). Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms. Brain, Behavior, & Immunity - Health, 47, 101018. https://doi.org/10.1016/j.bbih.2025.101018

Vancouver

Yasuno F, Nakagome K, Omachi Y, Kimura Y, Ogata A, Ikenuma H, et al. Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms. Brain, Behavior, & Immunity - Health. 2025;47:101018. doi:10.1016/j.bbih.2025.101018

BibTeX
@article{Yasuno2025,
  author = {Yasuno, Fumihiko and Nakagome, Kazuyuki and Omachi, Yoshie and Kimura, Yasuyuki and Ogata, Aya and Ikenuma, Hiroshi and Abe, Junichiro and Minami, Hiroyuki and Nihashi, Takashi and Yokoi, Kastunori and Hattori, Saori and Shimoda, Nobuyoshi and Kasuga, Kensaku and Ikeuchi, Takeshi and Takeda, Akinori and Sakurai, Takashi and Ito, Kengo and Kato, Takashi},
  title = {Leptin and inflammatory pathways in the Alzheimer's disease continuum: Implications for glial activation and neuropsychiatric symptoms},
  journal = {Brain, Behavior, & Immunity - Health},
  year = {2025},
  volume = {47},
  pages = {101018},
  doi = {10.1016/j.bbih.2025.101018}
}
Kostenlos starten →